SMC
Smith, Moore & Co’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $624K | Sell |
4,935
-175
| -3% | -$22.1K | 0.05% | 271 |
|
2025
Q1 | $654K | Sell |
5,110
-50
| -1% | -$6.4K | 0.06% | 254 |
|
2024
Q4 | $682K | Hold |
5,160
| – | – | 0.06% | 248 |
|
2024
Q3 | $751K | Sell |
5,160
-100
| -2% | -$14.6K | 0.07% | 225 |
|
2024
Q2 | $722K | Buy |
5,260
+159
| +3% | +$21.8K | 0.07% | 216 |
|
2024
Q1 | $700K | Sell |
5,101
-199
| -4% | -$27.3K | 0.07% | 220 |
|
2023
Q4 | $672K | Sell |
5,300
-1,251
| -19% | -$159K | 0.08% | 211 |
|
2023
Q3 | $759K | Sell |
6,551
-90
| -1% | -$10.4K | 0.1% | 181 |
|
2023
Q2 | $799K | Buy |
6,641
+329
| +5% | +$39.6K | 0.1% | 183 |
|
2023
Q1 | $815K | Sell |
6,312
-25
| -0.4% | -$3.23K | 0.11% | 173 |
|
2022
Q4 | $832K | Sell |
6,337
-25
| -0.4% | -$3.28K | 0.12% | 171 |
|
2022
Q3 | $744K | Buy |
6,362
+201
| +3% | +$23.5K | 0.11% | 170 |
|
2022
Q2 | $725K | Hold |
6,161
| – | – | 0.11% | 180 |
|
2022
Q1 | $803K | Sell |
6,161
-80
| -1% | -$10.4K | 0.11% | 186 |
|
2021
Q4 | $953K | Buy |
6,241
+155
| +3% | +$23.7K | 0.13% | 160 |
|
2021
Q3 | $984K | Buy |
6,086
+443
| +8% | +$71.6K | 0.15% | 138 |
|
2021
Q2 | $971K | Sell |
5,643
-688
| -11% | -$118K | 0.15% | 146 |
|
2021
Q1 | $953K | Buy |
6,331
+736
| +13% | +$111K | 0.15% | 139 |
|
2020
Q4 | $795K | Sell |
5,595
-204
| -4% | -$29K | 0.15% | 133 |
|
2020
Q3 | $785K | Hold |
5,799
| – | – | 0.16% | 122 |
|
2020
Q2 | $745K | Buy |
5,799
+325
| +6% | +$41.8K | 0.16% | 113 |
|
2020
Q1 | $590K | Buy |
5,474
+260
| +5% | +$28K | 0.16% | 131 |
|
2019
Q4 | $628K | Sell |
5,214
-400
| -7% | -$48.2K | 0.13% | 148 |
|
2019
Q3 | $559K | Buy |
5,614
+71
| +1% | +$7.07K | 0.12% | 157 |
|
2019
Q2 | $605K | Buy |
5,543
+400
| +8% | +$43.7K | 0.14% | 146 |
|
2019
Q1 | $614K | Buy |
5,143
+5
| +0.1% | +$597 | 0.15% | 143 |
|
2018
Q4 | $496K | Sell |
5,138
-586
| -10% | -$56.6K | 0.13% | 154 |
|
2018
Q3 | $698K | Buy |
5,724
+1,296
| +29% | +$158K | 0.16% | 130 |
|
2018
Q2 | $486K | Buy |
4,428
+247
| +6% | +$27.1K | 0.12% | 160 |
|
2018
Q1 | $446K | Buy |
4,181
+759
| +22% | +$81K | 0.12% | 170 |
|
2017
Q4 | $365K | Buy |
3,422
+2,283
| +200% | +$244K | 0.1% | 198 |
|
2017
Q3 | $380K | Buy |
1,139
+2
| +0.2% | +$667 | 0.11% | 194 |
|
2017
Q2 | $353K | Buy |
1,137
+92
| +9% | +$28.6K | 0.12% | 171 |
|
2017
Q1 | $306K | Buy |
1,045
+22
| +2% | +$6.44K | 0.11% | 182 |
|
2016
Q4 | $271K | Buy |
1,023
+332
| +48% | +$87.9K | 0.1% | 181 |
|
2016
Q3 | $200K | Buy |
+691
| New | +$200K | 0.08% | 204 |
|